Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine. Crane K, Bhat KRS, Grivas P, Necchi A, et al. Oncotarget 2026;17:381-387.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crane K, Bhat KRS, Grivas P, Necchi A, et al. Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine. Oncotarget 2026;17:381-387.
PMID: 42615885